Customs exemption for specified drug manufacturing inputs caps import duty where importer furnishes a use undertaking. The notification exempts specified goods under Chapters 28, 29 or 30 from customs duty in excess of reduced effective rates when imported for manufacture of bulk drugs, conditional on the importer furnishing an undertaking. The annexed Table lists items eligible for nil duty, a reduced ad valorem rate for Pleuromutilin, and a broader set of intermediates and reagents subject to a lower ad valorem duty, thereby capping duty at the specified rates for those inputs used in bulk drug production.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption for specified drug manufacturing inputs caps import duty where importer furnishes a use undertaking.
The notification exempts specified goods under Chapters 28, 29 or 30 from customs duty in excess of reduced effective rates when imported for manufacture of bulk drugs, conditional on the importer furnishing an undertaking. The annexed Table lists items eligible for nil duty, a reduced ad valorem rate for Pleuromutilin, and a broader set of intermediates and reagents subject to a lower ad valorem duty, thereby capping duty at the specified rates for those inputs used in bulk drug production.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
